Smoking is the Most Considerable Risk Factor for MI in This Patient
In this patient who smokes 20 cigarettes daily with stage 1 hypertension (BP 140/92), smoking represents the most considerable modifiable risk factor for myocardial infarction, particularly given the patient's apparent younger age context. While both smoking and hypertension significantly increase MI risk, the evidence demonstrates that smoking carries a disproportionately higher relative risk, especially in younger and middle-aged individuals.
Evidence-Based Rationale
Smoking's Powerful Impact on MI Risk
The guidelines consistently emphasize that smoking is the most common and harmful modifiable cardiovascular risk factor 1. Cigarette smoking accounts for up to 30% of all CVD deaths and more than doubles the risk of coronary artery disease 1. The 2007 European guidelines explicitly state that "stopping smoking after an MI is potentially the most effective of all preventive measures" 2.
The relative risk varies dramatically by age: Research shows that in patients under 45 years, smokers of 20+ cigarettes daily have a 33-fold higher risk of MI compared to non-smokers, versus only 2.5-fold in those over 65 3. Another study found that women smoking ≥20 cigarettes daily had a 6-fold increased incidence of MI, while men had a 3-fold increase 4. The smoking-related risk is particularly pronounced in younger individuals, where the relative risk can be 5-fold higher compared to doubled risk in older age groups 5.
Hypertension's Role
While hypertension at 140/92 mmHg (stage 1) does increase cardiovascular risk, the magnitude is more modest at this level. The guidelines note that hypertension confers approximately a 3-fold increase in cardiovascular risk on average 6. The CHARGE-AF risk score shows systolic BP contributes with a hazard ratio of 1.22 per 20 mmHg increment 7, and current smoking shows HR of 1.42 7.
Synergistic Effects
The combination is particularly dangerous: Research demonstrates that smokers with stage 3 hypertension who smoke ≥20 pack-years have a 3.06-fold increased risk of CVD mortality compared to never-smokers with stage 1 hypertension 8. However, at the stage 1 hypertension level (140/92), smoking remains the dominant modifiable risk factor.
Clinical Implications
Immediate Priority Actions
- Smoking cessation must be the highest priority intervention 9, 1, 2
- Within 1 year of quitting, cardiovascular event risk reduces by approximately 50% 1
- The benefit of smoking cessation exceeds that of antiplatelet drugs or statins in patients with preexisting CVD 1
- Risk returns to near-baseline within 2-5 years of cessation 10
Blood Pressure Management
- The BP of 140/92 requires lifestyle modification initially 10
- If BP remains >140/90 after 3 months of lifestyle changes, add antihypertensive medication 10
- Target BP <140/90 mmHg 10
Common Pitfalls
Do not underestimate smoking's impact simply because hypertension is also present. The evidence clearly shows smoking carries higher relative risks, particularly in younger patients. The "pack-a-day" habit (20 cigarettes) places this patient in the high-risk smoking category where relative risks are maximized 4, 3.
Avoid the trap of treating only the "measurable" risk factor (BP) while neglecting smoking cessation counseling. The EUROASPIRE III survey found that evidence-based smoking cessation treatment was consistently underused despite its proven superiority 5.
Age Consideration
While age is listed as an option, it is non-modifiable. Among the modifiable risk factors presented, smoking takes clear precedence over the stage 1 hypertension in terms of relative risk magnitude and immediate intervention benefit, especially if this patient is younger than 65 years old.